The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 09, 2019
Filed:
Mar. 30, 2016
Applicant:
Takeda Pharmaceutical Company Limited, Chuo-ku, Osaka-shi, Osaka, JP;
Inventors:
Ryo Mizojiri, Kanagawa, JP;
Moriteru Asano, Kanagawa, JP;
Daisuke Tomita, Kanagawa, JP;
Hiroshi Banno, Kanagawa, JP;
Michiko Tawada, Kanagawa, JP;
Noriyuki Nii, Kanagawa, JP;
Krista E. Gipson, Medford, MA (US);
Hironobu Maezaki, Kanagawa, JP;
Shuntarou Tsuchiya, Kanagawa, JP;
Mayumi Imai, Kanagawa, JP;
Yuichiro Amano, Kanagawa, JP;
Assignee:
Takeda Pharmaceutical Company Limited, Osaka, JP;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 213/65 (2006.01); A61K 31/165 (2006.01); A61K 31/167 (2006.01); A61K 31/277 (2006.01); A61K 31/381 (2006.01); A61K 31/402 (2006.01); A61K 31/415 (2006.01); A61K 31/42 (2006.01); A61K 31/421 (2006.01); A61K 31/426 (2006.01); A61K 31/427 (2006.01); A61K 31/44 (2006.01); A61K 31/4412 (2006.01); A61K 31/4436 (2006.01); A61K 31/4439 (2006.01); A61K 31/444 (2006.01); A61K 31/451 (2006.01); A61K 31/454 (2006.01); A61K 31/4965 (2006.01); A61K 31/50 (2006.01); A61K 31/501 (2006.01); A61K 31/505 (2006.01); A61K 31/506 (2006.01); C07D 213/75 (2006.01); C07D 213/81 (2006.01); C07D 231/12 (2006.01); C07D 333/20 (2006.01); C07D 401/04 (2006.01); C07D 237/14 (2006.01); C07D 239/34 (2006.01); C07D 409/04 (2006.01); C07D 413/04 (2006.01); C07D 241/18 (2006.01); C07D 417/04 (2006.01); C07C 233/18 (2006.01); C07C 233/47 (2006.01); C07D 261/08 (2006.01); C07D 263/32 (2006.01); C07D 263/42 (2006.01); C07D 207/08 (2006.01); C07D 207/12 (2006.01); C07D 277/34 (2006.01); C07D 211/44 (2006.01); C07D 213/643 (2006.01); C07D 213/69 (2006.01); C07C 233/25 (2006.01); C07C 255/54 (2006.01); C07D 211/46 (2006.01); C07D 213/74 (2006.01); C07D 401/12 (2006.01); C12N 9/99 (2006.01); C12N 15/09 (2006.01);
U.S. Cl.
CPC ...
C07D 213/65 (2013.01); A61K 31/165 (2013.01); A61K 31/167 (2013.01); A61K 31/277 (2013.01); A61K 31/381 (2013.01); A61K 31/402 (2013.01); A61K 31/415 (2013.01); A61K 31/42 (2013.01); A61K 31/421 (2013.01); A61K 31/426 (2013.01); A61K 31/427 (2013.01); A61K 31/44 (2013.01); A61K 31/444 (2013.01); A61K 31/4412 (2013.01); A61K 31/4436 (2013.01); A61K 31/4439 (2013.01); A61K 31/451 (2013.01); A61K 31/454 (2013.01); A61K 31/4965 (2013.01); A61K 31/50 (2013.01); A61K 31/501 (2013.01); A61K 31/505 (2013.01); A61K 31/506 (2013.01); C07C 233/18 (2013.01); C07C 233/25 (2013.01); C07C 233/47 (2013.01); C07C 255/54 (2013.01); C07D 207/08 (2013.01); C07D 207/12 (2013.01); C07D 211/44 (2013.01); C07D 211/46 (2013.01); C07D 213/643 (2013.01); C07D 213/69 (2013.01); C07D 213/74 (2013.01); C07D 213/75 (2013.01); C07D 213/81 (2013.01); C07D 231/12 (2013.01); C07D 237/14 (2013.01); C07D 239/34 (2013.01); C07D 241/18 (2013.01); C07D 261/08 (2013.01); C07D 263/32 (2013.01); C07D 263/42 (2013.01); C07D 277/34 (2013.01); C07D 333/20 (2013.01); C07D 401/04 (2013.01); C07D 401/12 (2013.01); C07D 409/04 (2013.01); C07D 413/04 (2013.01); C07D 417/04 (2013.01); C07C 2601/02 (2017.05); C07C 2601/14 (2017.05); C12N 9/99 (2013.01); C12N 15/09 (2013.01);
Abstract
The present invention relates to a compound which may be useful as an agent for the prophylaxis or treatment of cancer, hepatitis, hepatic fibrosis, fatty liver and the like.